Skip to content

CapnoPharm

BREAKING NEWS: Capnopharm has been awarded the Seal of Excellence by the European Commission following evaluation of its project for the development, validation, and commercialisation of a novel drug-device combination for treating peritoneal cancer.

BREAKING NEWS: Capnopharm has been awarded the Seal of Excellence by the European Commission following evaluation of its project for the development, validation, and commercialisation of a novel drug-device combination for treating peritoneal cancer.
CAPNOPHARM.jpg
  • About Us
    • Company
    • Mission
    • Leadership
    • Careers
    • Contact
  • Business
    • Sales
    • Global Footprint
    • Services
  • Science
    • Area of Focus
    • Clinical Trials
    • Case Studies
  • Technology
    • CapnoPen®
    • CapnoTip®
    • PIPAC
    • Animation Video
  • News
  • Awards
  • Investors
Menu
  • About Us
    • Company
    • Mission
    • Leadership
    • Careers
    • Contact
  • Business
    • Sales
    • Global Footprint
    • Services
  • Science
    • Area of Focus
    • Clinical Trials
    • Case Studies
  • Technology
    • CapnoPen®
    • CapnoTip®
    • PIPAC
    • Animation Video
  • News
  • Awards
  • Investors

© 2025 CapnoPharm GmbH   |   ALL RIGHTS RESERVED

Data Privacy    |     Impressum    |   Terms and Conditions